Type of financial instrument | Financial instrument | ISIN code | Nature of transaction | Linked to the exercise of a share option programme | Volume | Unit | Price per unit | Currency code | Transaction date | Place of the transaction |
---|---|---|---|---|---|---|---|---|---|---|
Share | Xbrane Biopharma AB | SE0007789409 | Disposal | 4,000 | Quantity | 32.05 | SEK | 12/09/2023 | NASDAQ STOCKHOLM AB | |
Share | Xbrane Biopharma AB | SE0007789409 | Acquisition | 4,000 | Quantity | 32.25 | SEK | 12/09/2023 | NASDAQ STOCKHOLM AB | |
Share | Xbrane Biopharma AB | SE0007789409 | Disposal | 2,000 | Quantity | 31.07 | SEK | 11/09/2023 | NASDAQ STOCKHOLM AB | |
Share | Xbrane Biopharma AB | SE0007789409 | Exercise increase | 4,320 | Quantity | 0.2242 | SEK | 08/09/2023 | Outside a trading venue | |
Subcription warrant | Xbrane Biopharma AB | SE0007789409 | Allotment | 4,320 | Quantity | 0.00 | SEK | 08/09/2023 | Outside a trading venue | |
Subcription warrant | Xbrane Biopharma AB | SE0007789409 | Exercise decrease | 4,320 | Quantity | 0.00 | SEK | 08/09/2023 | Outside a trading venue |
Financial instrument | ISIN code | Nature of transaction | Transaction date | Place of the transaction | Volume | Weighted average price |
---|---|---|---|---|---|---|
Xbrane Biopharma AB | SE0007789409 | Disposal | 12/09/2023 | NASDAQ STOCKHOLM AB | 4,000 (Quantity) | 32.05 SEK |
Xbrane Biopharma AB | SE0007789409 | Acquisition | 12/09/2023 | NASDAQ STOCKHOLM AB | 4,000 (Quantity) | 32.25 SEK |
Xbrane Biopharma AB | SE0007789409 | Disposal | 11/09/2023 | NASDAQ STOCKHOLM AB | 2,000 (Quantity) | 31.07 SEK |
Xbrane Biopharma AB | SE0007789409 | Exercise increase | 08/09/2023 | Outside a trading venue | 4,320 (Quantity) | 0.2242 SEK |
Xbrane Biopharma AB | SE0007789409 | Allotment | 08/09/2023 | Outside a trading venue | 4,320 (Quantity) | 0.00 SEK |
Xbrane Biopharma AB | SE0007789409 | Exercise decrease | 08/09/2023 | Outside a trading venue | 4,320 (Quantity) | 0.00 SEK |